Regeneron Pharmaceuticals (REGN)

Income Before Tax

$5.17B

TTM · Period ending: · USD

REGN logo

REGN Income Before Tax

Latest reported$5.17B
REGN Pre-Tax Income ($0.00 → $5.17B)
High-resolution chart · PNG

REGN income before tax history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Income Before Tax — Annual fiscal periods (USD)
Period endingIncome Before Tax (USD)
5,230,700,000
4,779,900,000
4,199,300,000
4,858,800,000
9,325,800,000
3,810,400,000
2,429,100,000
2,553,500,000
2,078,511,000
1,329,815,000
1,225,097,000
775,747,000
713,360,000
414,421,000
-222,892,000
-104,468,000
-71,952,000
-80,359,000
-93,557,000
-91,107,000
124,421,000
53,874,000
-95,526,000
-112,518,000
-73,523,000
-29,851,000
-22,800,000
-8,200,000
-7,500,000
-17,300,000
-7,600,000
0
0
0
-4,400,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.